Long-Term Survival Outcomes of Metabolically Supported Chemotherapy with Gemcitabine-Based or FOLFIRINOX Regimen Combined with Ketogenic Diet, Hyperthermia, and Hyperbaric Oxygen Therapy in Metastatic Pancreatic Cancer: A Letter to the Editor

Thumbnail

View/Open

Date

2021

Author

Ergözen, Serkan
Gümüş, Tuna

Metadata

Show full item record

Citation

Ergözen S, Gümüş T. Long-Term Survival Outcomes of Metabolically Supported Chemotherapy with Gemcitabine-Based or FOLFIRINOX Regimen Combined with Ketogenic Diet, Hyperthermia, and Hyperbaric Oxygen Therapy in Metastatic Pancreatic Cancer: A Letter to the Editor. Complement Med Res. 2021 Feb 18:1-2. doi: 10.1159/000514475. Epub ahead of print. PMID: 33601369.

Abstract

Letter to the Editor

Source

Complementary Medicine Research

URI

https://pubmed.ncbi.nlm.nih.gov/33601369/
https://hdl.handle.net/20.500.12809/8965

Collections